Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
Afifi, S, Adel, N G, Devlin, S, Duck, E, Vanak, J, Landau, H, Chung, D J, Lendvai, N, Lesokhin, A, Korde, N, Reich, L, Landgren, O, Giralt, S, Hassoun, H
Published in Bone marrow transplantation (Basingstoke) (01.04.2016)
Published in Bone marrow transplantation (Basingstoke) (01.04.2016)
Get full text
Journal Article
Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma
Lendvai, N, Cohen, A D, Cho, H J
Published in Bone marrow transplantation (Basingstoke) (01.06.2015)
Published in Bone marrow transplantation (Basingstoke) (01.06.2015)
Get full text
Journal Article
Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center
Pozotrigo, M, Adel, N, Landau, H, Lesokhin, A, Lendvai, N, Chung, D J, Chimento, D, Riedel, E, Chen, X, Reich, L, Comenzo, R, Giralt, S, Hassoun, H
Published in Bone marrow transplantation (Basingstoke) (01.08.2013)
Published in Bone marrow transplantation (Basingstoke) (01.08.2013)
Get full text
Journal Article
CILTACABTAGENE AUTOLEUCEL VS STANDARD OF CARE IN LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: PHASE 3 CARTITUDE-4 SUBGROUP ANALYSIS BY CYTOGENETIC RISK
Mina, R, Dhakal, B, San-Miguel, J, Lendvai, N, Vogel, M, Li, K, Chen, D, Patel, N, Einsele, H, Martinez-Lopez, J
Published in Hematology, Transfusion and Cell Therapy (01.10.2024)
Published in Hematology, Transfusion and Cell Therapy (01.10.2024)
Get full text
Journal Article
Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients’ monitoring after transplantation
Zamarin, D, Giralt, S, Landau, H, Lendvai, N, Lesokhin, A, Chung, D, Koehne, G, Chimento, D, Devlin, S M, Riedel, E, Bhutani, M, Babu, D, Hassoun, H
Published in Bone marrow transplantation (Basingstoke) (01.03.2013)
Published in Bone marrow transplantation (Basingstoke) (01.03.2013)
Get full text
Journal Article
Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance
Zamarin, D, Devlin, S M, Arcila, M E, Landau, H, Lesokhin, A, Lendvai, N, Chung, D J, Chimento, D, Weltz, J, Babu, D, Giralt, S, Hassoun, H
Published in Leukemia (01.12.2013)
Published in Leukemia (01.12.2013)
Get full text
Journal Article
P46 SEER‐MEDICARE DATABASE: REAL‐WORLD TREATMENTS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE‐REFRACTORY RELAPSED MULTIPLE MYELOMA TREATED WITH 1–3 PRIOR LINES OF THERAPY, INCLUDING A PI AND IMID
Einsele, H., Dhakal, B., Potluri, R., Schecter, J., Deraedt, W., Lendvai, N., Slaughter, A., Lonardi, C., Nair, S., He, J., Voelker, J., Cost, P., Valluri, S., Yalniz, F., Pacaud, L., Yong, K.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P35 ANALYSIS OF DARATUMUMAB CLINICAL TRIALS: CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH 1-3 PRIOR LINES OF THERAPY
Einsele, H., Dhakal, B., Schecter, J. M., Roccia, T., Deraedt, W., Lendvai, N., Slaughter, A., Lonardi, C., Connors, K., Qi, K., Londhe, A., Carson, R., Voelker, J., Cost, P., Valluri, S., Florendo, E., Pacaud, L., Yong, K.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P899: REAL‐WORLD ASSESSMENT OF TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE‐REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE OPTUM DATABASE
Dhakal, B., Einsele, H., Potluri, R., Schecter, J., Deraedt, W., Lendvai, N., Slaughter, A., Lonardi, C., Nair, S., He, J., Joseph, N., Cost, P., Valluri, S., Yalniz, F., Pacaud, L., Yong, K.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
INCIDENCE, MITIGATION, AND MANAGEMENT OF NEUROLOGIC ADVERSE EVENTS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN CARTITUDE-2
Einsele, H, Parekh, S, Madduri, D, Santomasso, B, Pérez-Larraya, JG, Donk, NWV, Arnulf, B, Mateos, M, Braganca, KC, Varsos, H, Carrasco-Alfonso, MJ, Akram, M, Lendvai, N, Jackson, CC, Olyslager, Y, Zudaire, E, Li, C, Geng, D, Jakubowiak, A, Cohen, A
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Get full text
Journal Article
CD34-selected allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma
Koehne, G, Devlin, S, Landau, H, Hassoun, H, Lesokhin, A, Lendvai, N, Chung, D, Giralt, S
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Recombinant MAGE-A3 protein immunotherapy and peripheral blood lymphocyte (PBL) reconstitution induce strong antigen-specific humoral and cellular immune responses in patients undergoing autologous stem cell transplantation (ASCT) for consolidation of multiple myeloma (MM)
Lendvai, N, Cohen, A.D, Gnjatic, S, Jungbluth, A.A, Bertolini, S, Pan, L, Venhaus, R, Tsakos, I, Garcia, K, Thibodeau, L, Alpaugh, K, Cummings, N, Lehmann, F.F, Gruselle, O, Cho, H.J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
A Response Adapted Approach to Induction Treatment Yields acceptable Outcome in Patients with Multiple Myeloma (MM) undergoing Autologous Stem Cell transplantation (ASCT)
Shah, G.L, Weltz, J, Zhou, Q, Devlin, S.M, Landau, H, Chung, D.J, Lendvai, N, Lesokhin, A.M, Korde, N, Koehne, G, Giralt, S.A, Hassoun, H
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Ibrutinib in combination with low-dose dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: results from a multicenter phase 2 trial
Richardson, P.G, Bensinger, W.I, Huff, C.A, Costello, C.L, Lendvai, N, Berdeja, J.G, Anderson, L.D, Siegel, D.S, Jagannath, S, Laubach, J.P, Stockerl-Goldstein, K.E, Knapp, L, Kwei, L, Clow, F, Graef, T, Bilotti, E, Vij, R
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice
Jurczyszyn, Artur, Grzasko, Norbert, Gozzetti, Alessandro, Czepiel, Jacek, Cerase, Alfonso, Hungria, Vania, Crusoe, Edvan, Silva Dias, Ana Luiza Miranda, Vij, Ravi, Fiala, Mark A., Caers, Jo, Rasche, Leo, Nooka, Ajay K., Lonial, Sagar, Vesole, David H., Philip, Sandhya, Gangatharan, Shane, Druzd‐Sitek, Agnieszka, Walewski, Jan, Corso, Alessandro, Cocito, Federica, Vekemans, Marie‐Christine M., Atilla, Erden, Beksac, Meral, Leleu, Xavier, Davila, Julio, Badros, Ashraf, Aneja, Ekta, Abildgaard, Niels, Kastritis, Efstathios, Fantl, Dorotea, Schutz, Natalia, Pika, Tomas, Butrym, Aleksandra, Olszewska‐Szopa, Magdalena, Usnarska‐Zubkiewicz, Lidia, Usmani, Saad Z., Nahi, Hareth, Chim, Chor S, Shustik, Chaim, Madry, Krzysztof, Lentzsch, Suzanne, Swiderska, Alina, Helbig, Grzegorz, Guzicka‐Kazimierczak, Renata, Lendvai, Nikoletta, Waage, Anders, Andersen, Kristian T., Murakami, Hirokazu, Zweegman, Sonja, Castillo, Jorge J.
Published in American journal of hematology (01.06.2016)
Published in American journal of hematology (01.06.2016)
Get full text
Journal Article
Web Resource
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention
Bausch, Birke, Schiavi, Francesca, Ni, Ying, Welander, Jenny, Patocs, Attila, Ngeow, Joanne, Wellner, Ulrich, Malinoc, Angelica, Taschin, Elisa, Barbon, Giovanni, Lanza, Virginia, Söderkvist, Peter, Stenman, Adam, Larsson, Catharina, Svahn, Fredrika, Chen, Jin-Lian, Marquard, Jessica, Fraenkel, Merav, Walter, Martin A, Peczkowska, Mariola, Prejbisz, Aleksander, Jarzab, Barbara, Hasse-Lazar, Kornelia, Petersenn, Stephan, Moeller, Lars C, Meyer, Almuth, Reisch, Nicole, Trupka, Arnold, Brase, Christoph, Galiano, Matthias, Preuss, Simon F, Kwok, Pingling, Lendvai, Nikoletta, Berisha, Gani, Makay, Özer, Boedeker, Carsten C, Weryha, Georges, Racz, Karoly, Januszewicz, Andrzej, Walz, Martin K, Gimm, Oliver, Opocher, Giuseppe, Eng, Charis, Neumann, Hartmut P H
Published in JAMA oncology (01.09.2017)
Published in JAMA oncology (01.09.2017)
Get more information
Journal Article
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results
Richardson, Paul G., Bensinger, William I., Huff, Carol Ann, Costello, Caitlin L., Lendvai, Nikoletta, Berdeja, Jesus G., Anderson, Larry D., Siegel, David S., Lebovic, Daniel, Jagannath, Sundar, Laubach, Jacob P., Stockerl‐Goldstein, Keith E., Kwei, Long, Clow, Fong, Elias, Laurence, Salman, Zeena, Graef, Thorsten, Bilotti, Elizabeth, Vij, Ravi
Published in British journal of haematology (01.03.2018)
Published in British journal of haematology (01.03.2018)
Get full text
Journal Article
Long-term use of cyclosporine in cardiac transplantation: the Pitié experience
Dorent, R., Tezenas, S., Ghossoub, J.J., Leger, P., Lendvai, N., Vaissier, E., Levasseur, J.P., Eslami, M., Pavie, A., Gandjbakhch, I.
Published in Transplantation proceedings (01.05.2002)
Published in Transplantation proceedings (01.05.2002)
Get full text
Journal Article
Conference Proceeding
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
Mailankody, Sham, Salcedo, Meghan, Tavitian, Elizabet, Korde, Neha, Lendvai, Nikoletta, Hassoun, Hani, Lesokhin, Alexander M., Lahoud, Oscar Boutros, Smith, Eric L., Hultcrantz, Malin, Devlin, Sean M., Landgren, Ola
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2019)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2019)
Get full text
Journal Article
Conference Proceeding
A Pilot Study of T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation With Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients With Relapsed Multiple Myeloma and High-Risk Cytogenetics
Koehne, G, Landau, H, Hassoun, H, Lesokhin, A, Lendvai, N, Rosenzweig, M, Chung, D.J, Young, J.W, Giralt, S
Published in Biology of blood and marrow transplantation (2011)
Published in Biology of blood and marrow transplantation (2011)
Get full text
Journal Article